Effect of omega-3 plus vitamin E supplementation in treatment of patients with Parkinson's

Phase 2

• Conditions: Parkinson disease.; Parkinson disease

• Registration Number: IRCT2017061234497N1
• Lead Sponsor: Kashan University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 7 October 2019

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 40

Inclusion Criteria

Patients with Parkinson's; aged 50 to 80 years.

Exclusion Criteria

Subjects who were already taking omega-3 and/or vitamin E
Subjects who were taking DDP4 inhibitors, statins and anti-inflammatory drugs
Subjects who had depression and had severe psychosis.

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Tumor necrosis factor alpha. Timepoint: At the beginning of the study and after 12 weeks of intervention. Method of measurement: PCR.;Interleukin-1. Timepoint: At the beginning of the study and after 12 weeks of intervention. Method of measurement: PCR.;Interleukin-8. Timepoint: At the beginning of the study and after 12 weeks of intervention. Method of measurement: PCR.

Secondary Outcome Measures

Name	Time	Method
Peroxisome proliferator–activated receptor ? (PPAR?). Timepoint: At the beginning of the study and after 12 weeks of intervention. Method of measurement: PCR.;Low Density Lipoprotein Receptor (LDLR). Timepoint: At the beginning of the study and after 12 weeks of intervention. Method of measurement: PCR.